The effect of an increased venous return on the stroke volume. Introduction: Cardiac output is a term that is defined as the amount of blood that is pumped in a minute by the left ventricle. The cardiac output of an individual can be adjusted due to the changes in the stroke volume or in the heart rate. The stroke volume denoted as SV refers to the amount of blood that is pumped out of a ventricle at the time of every contraction. Venous return is one of the factors that affect the EDV (End-Diastolic Volume). It is the blood amount that comes back to the heart with the help of veins.

Question

Want to see the full answer?

Answer 1

Question

Chapter 20, Problem 16CP

Summary Introduction

To determine:

The effect of an increased venous return on the stroke volume.

Introduction:

Cardiac output is a term that is defined as the amount of blood that is pumped in a minute by the left ventricle. The cardiac output of an individual can be adjusted due to the changes in the stroke volume or in the heart rate. The stroke volume denoted as SV refers to the amount of blood that is pumped out of a ventricle at the time of every contraction. Venous return is one of the factors that affect the EDV (End-Diastolic Volume). It is the blood amount that comes back to the heart with the help of veins.

Expert Solution & Answer

Want to see the full answer?

Check out a sample textbook solution

See solution

Students have asked these similar questions

Outline a method for using apomixis to maintain feminized CannabisAssume apomixis is controlled by a single dominant gene. You can choose the type of apomixis: obligate or facultative, gametophytic or sporophytic. Discuss advantages and disadvantages of your proposed method.

Kinetics: One-Compartment First-Order Absorption 1. In vivo testing provides valuable insight into a drug’s kinetics. Assessing drug kinetics following multiple routes of administration provides greater insight than a single route of administration alone. The following data was collected in 250-g rats following bolus IV, oral (PO), and intraperitoneal (ip) administration. Using this data and set of graphs, determine:(calculate for each variable) (a) k, C0, V, and AUC* for the bolus iv data (b) k, ka, B1, and AUC* for the po data c) k, ka, B1, and AUC* for the ip data (d) relative bioavailability for po vs ip, Fpo/Fip (e)absolute ip bioavailability, Fip (f) absolute po bioavailability, Fpo

3. A promising new drug is being evaluated in human trials. Based on preliminary human tests, this drug is most effective when plasma levels exceed 30 mg/L. Measurements from preliminary tests indicate the following human pharmacokinetic parameter values: t1/2,elim = 4.6hr, t1/2,abs = 0.34hr, VD = 0.29 L/kg, Foral = 72%. Based on these parameters, estimate the following if a 49 kg woman were to receive a 1000mg oral dose of this drug: (a) Estimate the plasma concentration of the drug at 1hr, 6 hr, and 20hr after taking the drug ( Concentration estimate) (b) Estimate the time for maximum plasma concentration (tmax). (c) Estimate the maximum plasma concentration (Cmax). (d) Estimate the time at which the plasma level first rises above 30 mg/L. (Note this is a trial and error problem where you must guess a time, plug it into the concentration equation, and determine if it is close to 30 mg/L. Hint: based on part (a) it should be apparent that the answer is less than 1hr.) (e)…